No Data
No Data
Goldman Sachs Raises Obesity Drug Market Estimate to $130B
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday.The Boston-based company announced preclinical data for its novel "G-Protein-Coupled Receptor 119 (GPR11
NeuroBo Says DA-1241, Wegovy Combo Shows Potential in Treating MASH
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersMustang Bio (NASDAQ:MBIO) stock increased by 51.6% to $0.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.8 million. NeuroBo Pharmaceuticals (NASD
Express News | NeuroBo Pharmaceuticals Sees Reporting Top-Line Data From Both Parts of Ongoing Phase 2a Clinical Trial in Mash in Q4 of This Year
Express News | NeuroBo Pharmaceuticals' Da-1241 in Combination With Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical Mash Models Compared to Either Treatment, Alone
No Data
Mcsnacks H Tupack : stay away. Offering in file